Screening patients who are at high risk for diabetes does not reduce their all-cause, cardiovascular, or diabetes-related mortality within 10 years, according to a study published October 4 in The Lancet.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Screening for those at high risk for T2DM does not reduce mortality within 10 years, study finds

Newsletter